Vera Therapeutics Statistics
NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
25.45-1.30 (-4.86%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Vera Therapeutics by the numbers
Vera Therapeutics has a market capitalization of $1.84 billion based on 72.30M shares outstanding. With trailing EPS of $-5.90, Vera Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.9% below its 50-day average and 28.7% below its 200-day average.
Average daily trading volume is 1.95M shares, or about $49.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VERA valuation vs. peer median
| Metric | VERA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.84B | $1.84B | -0% |
| Avg. volume | 1.95M | 1.23M | +59% |
Peer median across 8 companies: SEPN, IMNM, MRVI, BHVN, ZYME, TRVI, HRMY, ETON.
Valuation
- Market cap
- $1.84B
- EPS (TTM)
- $-5.90
- Shares outstanding
- 72.30M
Price and trading
- Previous close
- 26.75
- Open
- 26.37
- Day range
- 25.16 – 27.15
- 52-week range
- 25.08 – 56.05
- 52-week change
- -10.58%
- Beta
- —
- Volume
- 1.37M
- Average volume
- 1.95M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.84B
- Forward Pe
- -6.50
- Eps
- -5.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 56.05
- Week52 Low
- 25.08
- Avg Volume
- 1.95M
- Shares Outstanding
- 72.30M
- Ma50
- 30.25
- Ma200
- 35.71
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -54.59%
- Pct From52w Low
- 1.48%